Annual Cash & Cash Equivalents
$112.52 M
-$8.71 M-7.19%
31 December 2023
Summary:
IGM Biosciences annual cash & cash equivalents is currently $112.52 million, with the most recent change of -$8.71 million (-7.19%) on 31 December 2023. During the last 3 years, it has fallen by -$128.56 million (-53.33%). IGMS annual cash & cash equivalents is now -53.33% below its all-time high of $241.08 million, reached on 31 December 2020.IGMS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$42.88 M
-$24.10 M-35.98%
30 September 2024
Summary:
IGM Biosciences quarterly cash and cash equivalents is currently $42.88 million, with the most recent change of -$24.10 million (-35.98%) on 30 September 2024. Over the past year, it has dropped by -$131.92 million (-75.47%). IGMS quarterly cash and cash equivalents is now -83.01% below its all-time high of $252.38 million, reached on 31 March 2021.IGMS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.2% | -75.5% |
| 3 y3 years | -53.3% | -74.1% |
| 5 y5 years | +5862.9% | -77.9% |
IGMS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -53.3% | at low | -80.6% | at low |
| 5 y | 5 years | -53.3% | +5862.9% | -83.0% | +57.1% |
| alltime | all time | -53.3% | >+9999.0% | -83.0% | +2172.1% |
IGM Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.88 M(-36.0%) |
| June 2024 | - | $66.97 M(-15.4%) |
| Mar 2024 | - | $79.17 M(-29.6%) |
| Dec 2023 | $112.52 M(-7.2%) | $112.52 M(-35.6%) |
| Sept 2023 | - | $174.79 M(+16.0%) |
| June 2023 | - | $150.70 M(+7.5%) |
| Mar 2023 | - | $140.16 M(+15.6%) |
| Dec 2022 | $121.23 M(-9.1%) | $121.23 M(-31.7%) |
| Sept 2022 | - | $177.41 M(-19.8%) |
| June 2022 | - | $221.27 M(+193.4%) |
| Mar 2022 | - | $75.42 M(-43.4%) |
| Dec 2021 | $133.33 M | $133.33 M(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $165.60 M(-32.7%) |
| June 2021 | - | $246.05 M(-2.5%) |
| Mar 2021 | - | $252.38 M(+4.7%) |
| Dec 2020 | $241.08 M(+571.7%) | $241.08 M(+783.6%) |
| Sept 2020 | - | $27.28 M(-14.2%) |
| June 2020 | - | $31.79 M(-33.8%) |
| Mar 2020 | - | $48.05 M(+33.9%) |
| Dec 2019 | $35.89 M(+1802.0%) | $35.89 M(-81.5%) |
| Sept 2019 | - | $193.68 M(+134.3%) |
| June 2019 | - | $82.67 M(+4281.1%) |
| Dec 2018 | $1.89 M(+336.8%) | $1.89 M |
| Dec 2017 | $432.00 K | - |
FAQ
- What is IGM Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IGM Biosciences?
- What is IGM Biosciences annual cash & cash equivalents year-on-year change?
- What is IGM Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for IGM Biosciences?
- What is IGM Biosciences quarterly cash and cash equivalents year-on-year change?
What is IGM Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of IGMS is $112.52 M
What is the all time high annual cash & cash equivalents for IGM Biosciences?
IGM Biosciences all-time high annual cash & cash equivalents is $241.08 M
What is IGM Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, IGMS annual cash & cash equivalents has changed by -$8.71 M (-7.19%)
What is IGM Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IGMS is $42.88 M
What is the all time high quarterly cash and cash equivalents for IGM Biosciences?
IGM Biosciences all-time high quarterly cash and cash equivalents is $252.38 M
What is IGM Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, IGMS quarterly cash and cash equivalents has changed by -$131.92 M (-75.47%)